Myelodysplastic syndromes (MDSs) belong to a group of clonal bone marrow malignancies.
In light of the emergence of new molecules, a significant contribution to the understanding of …

Simple Summary The world population is genetically and environmentally diverse. In
particular, genetic differences related to an ethnic factor may underlie differences in cancer …

Myelodysplastic syndromes (MDS) are a group of clonal hematological disease with high
risk of progression to AML. Accurate risk stratification is of importance for the proper …

Background. Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal stem
cell disorders characterized by ineffective hematopoiesis, cytopenias and a risk of …

Background The karyotype is a major determinant of prognosis in myelodysplastic syndrome
(MDS). Details of the cytogenetic profile of MDS in South Asia are limited because …

Myelodysplastic syndromes (MDS) are a heterogeneous group of neoplastic diseases of the
hematopoietic cells manifested by ineffective hematopoiesis and a tendency to transform …

Background Myelodysplastic syndrome (MDS), a heterogeneous group of hematopoietic
malignancy, has been shown to present different cytogenetic abnormalities, risk factors, and …

Background Myelodysplastic syndromes (MDS) are clonal stem cell disorders exhibiting
cytopenias, ineffective hematopoiesis and morphological dysplasia. Bone marrow …

Objectives The epidemiology of myelodysplastic syndromes (MDS) differs among countries.
Here, we present the first epidemiological indices determined for Poland. Methods Twenty …

Amaç: Myelodisplastik sendrom (MDS) kemik iliğinde anormal selüler proliferasyon, çevre
kanında, bir veya daha fazla hücre dizisinde sitopeni, kemik iliğinde displazi ve akut myeloid …